A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP6590 in Participants With Normal Weight, Overweight and Obesity

NCT07721597 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants Study
Overweight and Obese Adults
First in Man Study to Evaluate Initial Safety

Interventions

DRUG: ZP6590, solution for injection
DRUG: Placebo, solution for injection

Sponsor

Zealand Pharma